Humana ETF Leadership
HUM Etf | USD 269.78 5.37 2.03% |
Humana employs about 65.7 K people. The company is managed by 64 executives with a total tenure of roughly 299 years, averaging almost 4.0 years of service per executive, having 1026.25 employees per reported executive. Analysis of Humana's management performance can provide insight into the ETF performance.
David Jones Director Independent Director |
Kurt Hilzinger Chairman Independent Chairman of the Board |
Insider Sentiment 50
Impartial
Selling | Buying |
Latest Trades
2025-02-26 | Gilbert Ray Cisneros, Jr. | Acquired @ 255.06 | |||
2024-12-31 | Timothy S Huval | Disposed 3703 @ 256.26 | View |
Monitoring Humana's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Acquired vs Disposed
Filed vs Not Filed
Insider sentiment refers to the collective sentiment or feeling of Humana's insiders - typically its officers, directors, and beneficial owners holding more than a certain percentage of the company's stock - about the future prospects of Humana Inc. This sentiment is often gauged based on the trading activities of these insiders. If insiders are purchasing more shares of their own company, it may be interpreted as a bullish sentiment, indicating that they believe Humana's stock will rise in value. Conversely, if insiders are selling shares, it might be seen as bearish, suggesting they expect the stock price to drop.
Humana |
Humana's latest congressional trading
Congressional trading in companies like Humana Inc, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Humana by those in governmental positions are based on the same information available to the general public.
2025-03-07 | Representative Gil Cisneros | Acquired Under $15K | Verify | ||
2025-02-14 | Representative Michael McCaul | Acquired $15K to $50K | Verify | ||
2024-12-18 | Representative Michael McCaul | Acquired $50K to $100K | Verify | ||
2024-12-06 | Representative Ro Khanna | Acquired Under $15K | Verify | ||
2024-11-11 | Representative Ro Khanna | Acquired Under $15K | Verify | ||
2024-09-06 | Representative John James | Acquired Under $15K | Verify |
Humana Management Team Effectiveness
The company has Return on Asset of 0.0407 % which means that on every $100 spent on assets, it made $0.0407 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0741 %, implying that it generated $0.0741 on every 100 dollars invested. Humana's management efficiency ratios could be used to measure how well Humana manages its routine affairs as well as how well it operates its assets and liabilities.Humana Workforce Comparison
Humana Inc is rated # 5 ETF in number of employees as compared to similar ETFs. The total workforce of Health Care category is currently estimated at about 940,354. Humana holds roughly 65,680 in number of employees claiming about 7% of all ETFs under Health Care category.
The company has Net Profit Margin of 0.01 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of (0.01) %, which entails that for every $100 of revenue, it lost $0.01. Humana Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Humana insiders, such as employees or executives, is commonly permitted as long as it does not rely on Humana's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Humana insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Celeste Mellet over two months ago Insider Trading | ||
O'hara Michelle A. over two months ago Insider Trading | ||
Smith Brad D over two months ago Acquisition by Smith Brad D of tradable shares of Humana subject to Rule 16b-3 | ||
Raquel Bono over three months ago Acquisition by Raquel Bono of tradable shares of Humana subject to Rule 16b-3 | ||
Renaudin George Ii over six months ago Acquisition by Renaudin George Ii of 1241 shares of Humana subject to Rule 16b-3 |
Humana Notable Stakeholders
A Humana stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Humana often face trade-offs trying to please all of them. Humana's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Humana's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kurt Hilzinger | Independent Chairman of the Board | Profile | |
Bruce Broussard | CEO and President Director and Chairman of Executive Committee | Profile | |
Luis Olivera | Puerto President | Profile | |
Cynthia Zipperle | Senior Vice President, Chief Accounting Officer, Controller | Profile | |
Alan Wheatley | Segment President - Retail | Profile | |
James MBA | President COO | Profile | |
Christopher Hunter | Segment President, Group and Military Business | Profile | |
Susan Diamond | Chief Financial Officer, Segment President, Home Business | Profile | |
David Dintenfass | President Growth | Profile | |
John III | Senior President | Profile | |
William Fleming | Segment President, Pharmacy Solutions and Chief Corporate Affairs Officer | Profile | |
Bethanie Stein | President Pharmacy | Profile | |
George II | President Insurance | Profile | |
MD MBA | President CenterWell | Profile | |
Brian Kane | Chief Financial Officer | Profile | |
Sam Deshpande | Chief Technology Officer, Chief Risk Officer | Profile | |
Eric Tagliere | Senior CTO | Profile | |
David Jones | Independent Director | Profile | |
David Feinberg | Independent Director | Profile | |
Marissa Peterson | Independent Director | Profile | |
James OBrien | Independent Director | Profile | |
Frank DAmelio | Independent Director | Profile | |
Frank Bisignano | Independent Director | Profile | |
William McDonald | Independent Director | Profile | |
Karen Katz | Independent Director | Profile | |
Joseph Ruschell | Assistant VP | Profile | |
Joseph Ventura | Chief Legal Officer and Corporate Secretary | Profile | |
Vishal MD | Chief Officer | Profile | |
Susan Schick | Segment President Group and Military Business | Profile | |
Raquel Bono | Independent Director | Profile | |
Jorge Mesquita | Independent Director | Profile | |
W Dunbar | Independent Director | Profile | |
Heather Carroll | Chief Digital Health and Analytics Officer | Profile | |
Kathie Mancini | Regional operations | Profile | |
Kate Goodrich | Senior Officer | Profile | |
Timothy Wheatley | Segment Retail | Profile | |
Andrew Agwunobi | President - Home Solutions Business | Profile | |
Matt Berger | Regional Markets | Profile | |
Heather Cox | Chief Digital Health and Analytics Officer | Profile | |
Michelle OHara | Chief Officer | Profile | |
Jessica Clark | Senior Improvement | Profile | |
Jennifer Bazante | Chief Marketing Officer | Profile | |
Celeste Mellet | Chief Officer | Profile | |
Amy Fry | Sr Communications | Profile | |
Marcy Klevorn | Independent Director | Profile | |
Nwando Olayiwola | Senior Vice President Chief Health Equity Officer | Profile | |
Vishal Agrawal | Chief Strategy and Corporate Development Officer | Profile | |
Wayne Frederick | Independent Director | Profile | |
PharmD PharmD | Chief Solutions | Profile | |
Japan Mehta | Chief Officer | Profile | |
Erin Champlin | Senior Experience | Profile | |
Timothy Huval | Chief Human Resource Officer, Chief Administrative Officer | Profile | |
Sue Schick | President - Military and Specialty Businesses | Profile | |
Gilbert Stewart | Senior Products | Profile | |
T Wheatley | Segment President - Retail | Profile | |
Tracy Nolan | Senior MarketPoint | Profile | |
Samir Deshpande | Chief Information Officer | Profile | |
William Shrank | Chief Medical and Corporate Affairs Officer | Profile | |
John Garratt | Independent Director | Profile | |
Carolyn Tandy | Senior Vice President and Chief Inclusion and Diversity Officer | Profile | |
Jay Khosla | Senior Officer | Profile | |
JohnPaul Felter | Chief VP | Profile | |
Lisa Stoner | Vice Relations | Profile | |
Michael Koeberlein | Senior Vice President Chief Accounting Officer, Controller | Profile |
About Humana Management Performance
The success or failure of an entity such as Humana Inc often depends on how effective the management is. Humana management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Humana management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Humana management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky. Humana operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 95500 people.
The data published in Humana's official financial statements typically reflect Humana's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Humana's quantitative information. For example, before you start analyzing numbers published by Humana accountants, it's essential to understand Humana's liquidity, profitability, and earnings quality within the context of the Health Care Providers & Services space in which it operates.
Humana Workforce Analysis
Traditionally, organizations such as Humana use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Humana within its industry.Humana Manpower Efficiency
Return on Humana Manpower
Revenue Per Employee | 1.8M | |
Revenue Per Executive | 1.8B | |
Net Income Per Employee | 18.5K | |
Net Income Per Executive | 19M | |
Working Capital Per Employee | 5.6K | |
Working Capital Per Executive | 5.7M |
Other Information on Investing in Humana Etf
Humana financial ratios help investors to determine whether Humana Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Humana with respect to the benefits of owning Humana security.